$250.00

Packaging Size 5*3 ml
Strength 100 IU/ml
Packaging Type Box
Brand Novorapid Flexpen
Manufacturer Novo Nordisk
Usage / Application Personal
Storage Conditions 2 – 8 degree
Availability In Stock

                    NovoRapid FlexPen

NovoRapid FlexPen is a prefilled injection device containing Insulin aspart, a fast-acting insulin used to help control blood glucose levels in people with diabetes. It is designed for convenient, accurate dosing and is a prescription-only medication that must be used under medical supervision.


What Is Insulin Aspart?

Insulin aspart is a rapid-acting insulin analog that begins to work quickly after injection. It is used to manage blood sugar spikes that occur after meals in individuals with:

  • Type 1 diabetes
  • Type 2 diabetes (when insulin therapy is required)

It is commonly used as part of a broader diabetes management plan that includes diet, exercise, and possibly long-acting insulin.


Medical Classification

  • Active ingredient: Insulin aspart
  • Drug class: Rapid-acting insulin analog
  • Formulation: Prefilled FlexPen device
  • Administration: Subcutaneous injection
  • Status: Regulated prescription medication

How It Works

Insulin aspart helps regulate blood sugar by:

  • Facilitating the uptake of glucose into cells
  • Reducing glucose production by the liver
  • Controlling post-meal blood sugar spikes

It typically starts working within 10–20 minutes, peaks in about 1–3 hours, and lasts for 3–5 hours.


Indications and Uses

NovoRapid FlexPen is prescribed for:

  • Blood glucose control in diabetes mellitus
  • Mealtime (prandial) insulin therapy
  • Use in combination with long-acting insulin for comprehensive glucose management

Dosage and Administration

  • Dosage is individualized based on blood glucose levels, diet, and lifestyle
  • Injected subcutaneously in areas such as the abdomen, thigh, or upper arm
  • Typically administered just before or shortly after meals
  • Requires regular blood glucose monitoring

Always follow your healthcare provider’s instructions for dosing and timing.


Potential Side Effects

Common Side Effects

  • Hypoglycemia (low blood sugar)
  • Injection site reactions
  • Mild weight changes

Serious Side Effects

  • Severe hypoglycemia
  • Allergic reactions
  • Electrolyte imbalance (e.g., low potassium levels)

Immediate medical attention is required for severe symptoms.


Warnings and Precautions

  • Risk of hypoglycemia, especially with incorrect dosing
  • Monitor blood sugar levels regularly
  • Adjust dosage during illness, stress, or dietary changes
  • Use caution when combining with other diabetes medications

Device Features (FlexPen)

  • Prefilled, ready-to-use insulin pen
  • Dial-a-dose mechanism for precise dosing
  • Portable and convenient for daily use
  • Designed to reduce dosing errors

Storage Instructions

  • Store unused pens in a refrigerator (2°C to 8°C)
  • Do not freeze
  • In-use pens may be kept at room temperature for a limited period (follow label instructions)
  • Protect from direct heat and light

Legal and Regulatory Status

NovoRapid FlexPen is a regulated prescription medication in most countries. It should only be used under the guidance of a qualified healthcare provider.


Important Safety Information

  • Never share insulin pens
  • Always use a new needle for each injection
  • Dispose of needles safely
  • Carry a source of fast-acting sugar to manage hypoglycemia